Complete clinical review

Dive deeper

Open any topic for the complete explanation, evidence, clinical checkpoints, tables, and references.

What is the direct answer about reconstruction after Mohs surgery?

Direct Answer

Reconstruction after Mohs surgery should be treated as a second, linked decision that begins only after the oncologic question is resolved. The surgeon first establishes complete peripheral and deep margin clearance using the Mohs map. The final defect is then analyzed by missing tissue layers, functional subunits, tension vectors, tissue mobility, vascularity, host factors, and patient priorities. Only then should the surgeon select among second intention, linear closure, local flap, grafting, structural support, staged tissue transfer, delayed reconstruction, or collaboration.

The best reconstruction is not the most complex operation and not necessarily the shortest scar. It is the least burdensome method that restores durable coverage and function, controls distortion, respects blood supply, and leaves acceptable options if healing or surveillance does not proceed as expected.

How should clinicians use this reconstruction after Mohs surgery review?

Scope, Evidence Hierarchy, and Limits of This Review

This living review addresses reconstruction after Mohs surgery and closely related cutaneous oncologic defects. It does not prescribe one technique by defect diameter, provide universal wound-care schedules, or convert retrospective cosmetic ratings into a universal repair ranking.

The evidence base is uneven:

  1. Multisociety guidance provides a structured clinical framework but often rests on observational evidence and expert consensus.1 Its formal reconstruction scope centers on flaps, grafts, and tissue rearrangement; it does not comparatively evaluate second intention, simple closure, or every complex closure outside that definition. Its recommendations therefore should not be read as a universal ranking of all repair methods.
  2. Large prospective Mohs cohorts describe overall safety more reliably than they predict the risk of one complex repair.2,3
  3. Registry and claims analyses show practice patterns, not comparative effectiveness.4,5
  4. Single-center reconstructive cohorts can illuminate technique, feasibility, and complications but carry strong selection and operator effects.
  5. Site-specific systematic reviews often find heterogeneous defects, inconsistent outcome definitions, short follow-up, and limited independent assessment.6
  6. Patient-reported outcome studies appropriately broaden the endpoint beyond surgeon-rated appearance but remain sensitive to baseline expectations, case mix, and loss to follow-up.7

Accordingly, the most defensible output is a decision framework with bounded quantitative anchors—not a universal reconstructive league table.

Oncologic Clearance Comes Before Tissue Rearrangement

Oncologic Clearance Comes Before Tissue Rearrangement

Mohs surgery couples mapped excision with complete examination of the properly processed peripheral and deep surgical margin. When residual tumor is identified, the map directs additional removal only to the involved area. Randomized and observational data support a tissue-sparing advantage in selected basal cell carcinomas, particularly when subclinical extension makes fixed visible margins inefficient.[8–10]

That advantage matters reconstructively. Major undermining, flap transposition, or other tissue rearrangement can complicate later localization and re-excision if clinically meaningful tumor remains. National guidance therefore supports confirming clearance before major reconstruction after conventional excision as well.1,11,12

This is not a rule that every conventional excision must remain open until permanent sections return. Selected tumors may be closed immediately when the planned margin strategy, tumor risk, pathology workflow, and contingency for an involved margin make that reasonable. The more tissue a repair moves—and the more consequential reopening it would be—the more important it becomes to make margin certainty explicit before reconstruction.

This sequencing should not be mistaken for delayed planning. Preoperative reconstruction planning remains essential:

  • review tumor biology, prior treatment, and likely subclinical extension;
  • identify free margins, aesthetic units, and functional structures at risk;
  • examine laxity, scars, vascular territories, and donor sites;
  • clarify anticoagulants, nicotine exposure, immune status, diabetes, vascular disease, and anesthesia needs;
  • discuss a realistic hierarchy of possible repairs; and
  • arrange another specialist or setting in advance when the likely defect may require it.

The operative plan should be conditional rather than falsely precise. A statement such as “likely linear closure, with flap or graft if the defect reaches the lid margin” is more useful than promising a repair from the biopsy photograph.

Defect Analysis: Reconstruct the Missing Function, Not the Photograph

Defect Analysis: Reconstruct the Missing Function, Not the Photograph

The final defect should be described in more than centimeters. A useful analysis includes at least six dimensions.

Surface geometry

Diameter, shape, orientation, and relation to relaxed skin-tension lines influence whether a linear closure can distribute tension without standing cones or landmark displacement. Area alone does not capture closure mechanics.

Depth and missing layers

Skin-only loss differs from loss of subcutaneous volume, muscle, cartilage, periosteum, tendon covering, or mucosal lining. Reconstruction should replace the tissue needed for stability and function. Surface cover cannot compensate for absent nasal framework or eyelid posterior lamella.

Free margins and functional units

The eyelid margin, nostril rim, vermilion border, oral commissure, eyebrow, auricular rim, and hairline tolerate little unintended movement. The relevant question is not merely whether a wound can close, but whether the proposed vector will displace a structure that must remain stable.

Local tissue mobility and vector

The cheek may provide broad recruitment; the nasal tip and lower leg do not. A closure vector can be more consequential than defect size. The surgeon should predict the direction of primary and secondary tension after swelling and scar contraction, not only at the moment the sutures are tied.

Blood supply and tissue quality

Prior surgery, radiation, scarring, nicotine exposure, vascular disease, chronic edema, and wound depth can change both the donor tissue and recipient bed. The best color match is not always the safest tissue to move.

Host and care environment

Medical stability, bleeding risk, immune status, diabetes, frailty, mobility, anesthesia tolerance, ability to perform wound care, and reliability for staged follow-up may change the preferred reconstruction. Chronologic age alone is an inadequate decision variable.

Reconstructive Options Compared

Reconstructive Options Compared

Reconstructive Options Compared
OptionPrincipal reconstructive purposeAdvantagesFailure mode to anticipateEvidence boundary
Second intentionUses granulation, contraction, and epithelializationNo donor site or additional incision; preserves future options; can blend in selected contoursProlonged healing, contraction, contour depression/elevation, free-margin distortionSite- and defect-selected cohorts; no universal contour rule
Linear closureConverts the defect into a planned lineOne-stage, familiar care, efficient, often excellent when tissue is mobileExcessive tension, landmark pull, widening, standing conesStrong clinical experience; limited comparative trials
Local flapRecruits adjacent vascularized tissue and redirects tensionClose color/texture match; restores contour; protects free marginsTrapdoor change, pincushioning, vascular compromise, additional scar, vector errorMostly retrospective technique series
Full-thickness skin graftProvides surface cover without recruiting adjacent tissueAvoids local distortion; preserves other options; useful for broad superficial defectsPartial/complete loss, mismatch, depression, contractionRetrospective comparisons strongly confounded by wound selection
Composite or structural graftReplaces support as well as coverResists collapse or notching in selected three-dimensional defectsDonor morbidity, resorption, warping, vascular limitationsSmall series and expert technique literature
Staged interpolation flapTransfers reliable, often well-matched tissue across a bridgePowerful for deep or multilayer nasal/auricular defectsMultiple procedures, temporary pedicle, bleeding, infection, necrosis, patient burdenSelected cohorts establish feasibility, not universal superiority
Delayed reconstructionSeparates clearance, wound preparation, or coordination from definitive repairAllows pathology clarification, wound-bed evolution, medical optimization, or specialist planningOpen-wound interval, extra visit, scheduling burdenObservational data; indication confounding is substantial
Collaboration or referralAdds a capability, anesthesia environment, or multidisciplinary planExpands expertise and rescue resourcesFragmented ownership, additional visits, delayed communicationNo controlled evidence that one specialty model is universally superior

The “reconstructive ladder” remains a useful teaching model, but the surgeon need not climb one rung at a time. The related reconstructive elevator concept makes that judgment explicit: move directly to the option that restores the required function and form rather than escalating mechanically from the simplest named procedure.37 A flap may be less burdensome than forcing a high-tension linear closure; second intention may be more predictable than a graft in one concavity and unacceptable beside a free margin in another. The correct technique is the one that solves the dominant defect problem with the lowest total burden.

Timing: Immediate, Delayed, and Staged Reconstruction

Timing: Immediate, Delayed, and Staged Reconstruction

Same-day reconstruction is common because Mohs establishes margin clearance and the defect can then be repaired during one episode of care. In a TriNetX analysis of 607,214 Mohs cases recorded from 2006 through 2024, 19% had no same-day repair code; the other coded categories together accounted for roughly four out of five cases.4 The 19% category is not synonymous with failure and does not reveal intent. It can include second intention, referral, delayed reconstruction, or incomplete coding.

The multisociety reconstruction guideline recognizes both immediate and delayed strategies because high-quality comparative evidence is limited and timing is indication-dependent.1

Immediate repair generally fits when

  • margins are clear;
  • the defect and patient are suitable for the planned repair;
  • the needed expertise, anesthesia, monitoring, and rescue capability are available;
  • delay offers no meaningful oncologic or reconstructive advantage; and
  • the patient can safely complete the operation and aftercare.

Delay may be useful when

  • conventional pathology or other tumor information remains unresolved;
  • the recipient bed may benefit from an interval before grafting;
  • tissue viability or the true extent of injury requires observation;
  • infection, contamination, edema, or medical instability alters the plan;
  • another specialist or operative setting must be coordinated; or
  • the patient needs time to consider materially different reconstructions.

Staging is a technique, not indecision

Interpolation flaps and some multilayer reconstructions are intentionally completed over multiple procedures. The stage count depends on the flap, tissue requirements, perfusion strategy, patient, and surgeon. A paramedian forehead flap should not be described as universally two-stage; two- and three-stage strategies are both established.13

Historical nasal-graft data provide a bounded example of deliberate delay. In a selected cohort of nasal tip and ala wounds, full-thickness grafting delayed 12 to 14 days was associated with partial graft loss in 11% compared with 30% after immediate grafting.14 A later systematic review found the literature heterogeneous and did not convert that association into a universal rule.15

Linear Closure: Mechanics Matter More Than Scar Length

Linear Closure: Mechanics Matter More Than Scar Length

A linear closure is frequently the most efficient and sophisticated solution. The defect is converted into a fusiform or otherwise planned configuration, undermining is used selectively, and tension is distributed along a vector that protects adjacent landmarks.

Technical analysis should include:

  • direction of maximal extensibility;
  • deep fixation needed to offload the epidermal line;
  • risk of brow, eyelid, nostril, lip, or hairline displacement;
  • standing-cone placement;
  • dead space and hematoma risk;
  • scar placement within unit boundaries or natural creases when feasible; and
  • whether a longer line reduces rather than increases total deforming tension.

A “shorter scar” can be a poor endpoint when it requires high tension or landmark distortion. The clinically relevant comparison is predicted function, contour, and scar behavior over time.

Local Flaps: Match Tissue and Redirect Force

Local Flaps: Match Tissue and Redirect Force

Local flaps preserve a vascular connection while advancing, rotating, or transposing adjacent tissue. Their advantages are not limited to color match. They can recruit laxity from a favorable reservoir, restore volume, span an exposed structure, and redirect tension away from a free margin.

Flap design should account for:

  • vascular reliability and prior scars;
  • primary, secondary, and tertiary motion;
  • pivot restraint and arc of rotation;
  • thickness mismatch and subcutaneous bulk;
  • anticipated edema, pincushioning, and contraction;
  • incision placement across aesthetic units;
  • distal perfusion under tension; and
  • the cost of the donor defect.

Technique labels alone do not determine quality. A bilobed, advancement, rotation, transposition, or island flap should be justified by the defect mechanics rather than by habit.

Skin Grafts: Surface Coverage With a Different Tradeoff Profile

Skin Grafts: Surface Coverage With a Different Tradeoff Profile

A full-thickness skin graft separates donor tissue from its original circulation and depends on the recipient bed for plasmatic imbibition, inosculation, and revascularization. Grafting can preserve adjacent anatomy when local recruitment would distort a free margin, avoid a large flap, and maintain future reconstructive options.

The surgeon must evaluate:

  • recipient-bed vascularity and depth;
  • exposed cartilage, bone, tendon, or other poorly vascularized structures;
  • donor-site color, thickness, texture, and actinic match;
  • expected contraction and contour depression;
  • immobilization and hematoma prevention;
  • whether immediate, delayed, or staged grafting best fits the bed; and
  • the patient's tolerance for mismatch or later refinement.

Retrospective nasal comparisons have often rated flaps more favorably than grafts, but treatment assignment is strongly nonrandom. Flaps and grafts are selected for different subunits, depths, sizes, and patient factors. These studies support informed tendencies, not a universal cosmetic hierarchy.16

Second-Intention Healing: An Active Reconstruction

Second-Intention Healing: An Active Reconstruction

Second intention uses granulation, contraction, and epithelialization. It is not the absence of a plan. Its advantages include avoiding donor morbidity and additional incision lines, preserving future options, and allowing excellent blending in selected defects.

The concave-versus-convex rule is best understood as a prior probability, not an absolute. Outcome depends on:

Use the concave-versus-convex rule as a useful tendency alongside wound size, depth, free margins, and patient factors—not as an absolute prohibition.17–19

  • size and depth;
  • exposed cartilage, bone, tendon, or periosteum;
  • distance from a free margin;
  • regional contraction;
  • vascularity and edema;
  • patient healing capacity and wound-care ability; and
  • the functional consequence of contraction.[17–19]

In one observational nasal cohort, selected small, shallow wounds no deeper than superficial fat healed favorably; these cohort-derived measurements should not become universal cutoffs.18 Periocular second intention is also legitimate in selected defects, while larger defects can increase the risk of poor position or contour.20

Body-site transfer is unsafe. A selected facial wound may epithelialize in several weeks, whereas lower-leg wounds commonly heal more slowly and can carry different infection, edema, and care burdens.[21–23] The treating clinician's instructions should therefore control wound care; a universal online schedule is inappropriate.

In one retrospective cohort of Mohs and wide-local-excision wounds treated from 2012 through 2016, culture-confirmed infection was recorded in 6.8% of second-intention wounds versus 3.2% of sutured wounds (odds ratio 2.22, 95% CI 1.63–2.99).22 The abstract did not report the closure-group denominators, and the groups were not randomized. Lower-extremity wounds had the highest infection rate in that cohort. The clinically defensible conclusion is not that second intention is intrinsically unsafe, but that site, wound selection, ascertainment, and follow-up must travel with any infection comparison.

Site-Specific Reconstruction for reconstruction after Mohs surgery

Site-Specific Reconstruction

Nose: cover, contour, framework, lining, and airway

The nasal defect should be decomposed into separate missing components:

  1. external cover;
  2. three-dimensional contour;
  3. structural framework;
  4. internal lining; and
  5. airway stability.

Shallow skin-only defects may fit linear closure, local flap, grafting, or second intention depending on subunit, depth, tissue mobility, and free-margin risk. Deeper or full-thickness defects may need cartilage support, lining, and staged vascularized tissue. The paramedian forehead flap remains a powerful option for selected larger, deeper, or multilayer defects, but no universal size threshold or stage count should be taught.13,24

The final Mohs defect—not the preoperative photograph—determines whether support or lining is missing. A plan that replaces skin but permits alar collapse or airway narrowing is incomplete.

Eyelid and periocular region

Periocular reconstruction must preserve globe protection, blink, eyelid apposition, canthal support, tear drainage, and symmetry. The surgeon should identify anterior-lamellar loss, posterior-lamellar loss, margin involvement, canthal disruption, and lacrimal-system injury. Upper-lid mobility and lower-lid support impose different constraints.25,26

A 2023 systematic review included 3,678 periorbital repairs across 53 studies, but only three studies used a defined grading system, objective measurement, or independent cosmetic assessment.6 The literature therefore describes many workable techniques without supporting one universal cosmetic hierarchy.

Lip and perioral region

The endpoint includes oral competence, sensation, motion, the vermilion-cutaneous junction, commissure position, and aperture. A reconstruction that appears acceptable at rest may still impair eating, speech, or expression. Defect width is useful, but missing muscle, mucosa, and commissural anatomy must drive the plan.27

Ear

Auricular skin is thin, cartilage is exposed easily, and the rim is a free margin. Second intention, grafts, wedge closure, and local flaps can each be appropriate. The surgeon should anticipate notching, loss of projection, canal distortion, and chondritis rather than apply a generic facial algorithm.28

Cheek, forehead, and scalp

These regions often provide enough tissue for linear closure or local flaps, but secondary movement can displace the eyelid, eyebrow, hairline, or lip. On the scalp, limited mobility, periosteal status, hair-bearing alignment, and defect size influence whether closure, flap, graft, tissue expansion, or another strategy is appropriate.29,30

Hand and lower extremity

On the hand, tendon, nerve, joint, motion, and durable coverage can dominate cosmetic goals. Lower-extremity wounds often heal more slowly and have higher reported infection rates than selected facial wounds; edema, vascular disease, skin tension, and mobility further change the risk-benefit calculation. Facial second-intention timelines and infection estimates should not be transferred automatically.

Perioperative Risk, Anesthesia, and Operative Setting

Perioperative Risk, Anesthesia, and Operative Setting

The correct setting is the one that matches the operation, patient, monitoring needs, and rescue capability. Local anesthesia and an outpatient environment can support substantial reconstruction in selected patients, but “possible in the office” is not equivalent to “best in the office for every patient.”

Medication and infection-prevention decisions should remain repair- and patient-specific. Clinically necessary antiplatelet or anticoagulant therapy should not be stopped casually; any proposed change should be coordinated with the prescribing clinician and weighed against thrombotic risk. In the prospective REGESMOHS cohort, these therapies were associated with a small increase in hemorrhage, while the investigators concluded that the increase probably did not justify routine withdrawal.35

Antibiotic prophylaxis is similarly not an all-reconstruction rule. In a double-blind randomized trial of 154 adults scheduled for a flap or graft on the nose or ear in Australian primary-care skin-cancer clinics, 142 were analyzed. A single 2-g dose of cephalexin 40 to 60 minutes before incision was followed by a 30-day surgical-site infection in 1 of 73 patients (1.4%), compared with 8 of 69 (11.6%) receiving placebo.36 This is a useful signal for a narrowly defined higher-risk repair population, not a mandate for routine antibiotics after every Mohs closure. Allergy, antimicrobial stewardship, local resistance, institutional policy, and the specific wound remain controlling considerations.

Factors that may move a case toward a facility, broader anesthesia support, or another team include:

  • airway or internal lining reconstruction;
  • major blood-loss or hemostatic risk;
  • free-tissue transfer;
  • extensive cartilage or bone work;
  • severe anxiety or inability to tolerate awake staging;
  • significant cardiopulmonary disease;
  • need for prolonged monitoring;
  • limited outpatient rescue resources; and
  • surgeon or patient preference after an informed comparison.

Conversely, general anesthesia is not a complexity badge. Selected staged interpolation flaps and large repairs can be performed under local anesthesia by experienced teams.31,32 In a prospective cohort of 39 patients undergoing staged interpolation flaps in one outpatient Mohs center, mean satisfaction was 95 ± 1.7 of 100 and the experience was generally well tolerated.31 This establishes feasibility in selected patients, not setting superiority.

The risk must travel with the feasibility claim. A retrospective academic-center cohort of 436 large post-Mohs repairs performed under local anesthesia reported an overall complication rate of 16.1%.32 The cohort mixed flaps, grafts, and complex closures and cannot predict one patient's risk, but it appropriately prevents the conclusion that local anesthesia makes a large repair routine.

Outcomes: Safety, Function, Appearance, and Time

Outcomes: Safety, Function, Appearance, and Time

Overall safety

In a prospective multicenter cohort of 20,821 Mohs procedures at 23 centers, investigators recorded 149 adverse events, an overall rate of 0.72%, with no deaths or permanent disabilities.2 This is strong reassurance about Mohs care in aggregate. It should not be used to minimize the procedure-specific risk of a large flap, graft, staged reconstruction, anticoagulated patient, irradiated field, or lower-extremity wound.

A second prospective view comes from 5,017 patients treated at 22 Spanish centers in REGESMOHS, with 14,421 patient-years of follow-up.35 Investigators recorded 7.0% perioperative morbidity and 6.5% midterm or scar-related complications. Specific outcomes included hemorrhage in 0.9%, wound necrosis in 1.9%, dehiscence in 1.0%, infection in 0.9%, aesthetic scar alteration in 5.4%, and functional scar alteration in 1.7%. Larger and deeper tumors, unfinished clearance, and complex repair tracked with several outcomes; age and outpatient setting did not. These rates are more granular than a single overall number, but they still reflect case selection and cannot isolate the effect of a repair from the defect that required it.

Potential complications include:

  • bleeding or hematoma;
  • infection;
  • dehiscence;
  • partial or complete flap or graft loss;
  • necrosis or vascular compromise;
  • contour depression, pincushioning, or trapdoor change;
  • eyelid, nostril, lip, ear, or hairline distortion;
  • nerve symptoms;
  • delayed healing;
  • scar pain, pruritus, erythema, hypertrophy, or widening; and
  • revision.

Function

Functional outcomes should be defined by site: blink and corneal protection, airway and alar stability, oral competence and articulation, hand motion, durable tendon coverage, or lower-extremity mobility. “Cosmetically acceptable” is an incomplete endpoint when function has not been measured.

Appearance and patient-reported outcomes

Appearance should not be judged in the first postoperative weeks. Edema, erythema, firmness, contraction, and contour can evolve over months. In a multicenter prospective study, patient-reported appearance-related quality of life and aesthetic satisfaction continued to improve through one year after Mohs surgery.7 This supports longitudinal counseling; it does not guarantee that every scar becomes inconspicuous.

Why comparative cosmetic evidence remains weak

Technique comparisons often fail to control for the reason a technique was chosen. A flap may be used for a deeper or more functionally demanding wound than a graft, or vice versa. Surgeon-reported appearance, patient satisfaction, standardized photography, blinded assessment, and validated quality-of-life tools are not interchangeable endpoints. Short follow-up can also favor or penalize a technique before scar maturation.

Operator preference adds another layer. In 338 primary invasive nasal keratinocyte carcinomas reconstructed by 10 surgeons in one Veterans Affairs system, the adjusted predicted probability of choosing a flap or graft ranged from 7% to 99% despite adjustment for age, tumor diameter, and location.38 That study measures practice variation, not which surgeon chose correctly, but it shows why observational repair comparisons inherit strong surgeon-level selection effects.

The safest conclusion is usually conditional: a technique performed well in a selected cohort can be a sound option for similar defects in capable hands. It rarely proves universal superiority.

What does the evidence show about reconstruction after Mohs surgery?

Evidence by the Numbers

Evidence by the NumbersOverall Mohs safety is strong population context—not a complex-repair guarantee

Overall Mohs safety is strong population context—not a complex-repair guarantee

20,821 procedures / 149 adverse events / 0.72%

Population
Patients undergoing Mohs micrographic surgery at 23 US centers in a prospective multicenter cohort
Outcome
Adverse events associated with the procedure, including serious outcomes
Time horizon
Perioperative and postoperative follow-up reported for each procedure

What it means: Mohs surgery had a very low overall adverse-event rate, with no deaths or permanent disabilities in this cohort.

Limitations: The average combines many tumors, sites, repairs, and patient profiles. It does not estimate the risk of one large flap, graft, staged repair, irradiated field, anticoagulated patient, or lower-extremity wound.

References: 2

Evidence by the NumbersA selected nasal-graft cohort shows why timing can be a reconstructive variable

A selected nasal-graft cohort shows why timing can be a reconstructive variable

11% vs 30% partial graft loss

Population
Selected nasal tip and ala wounds receiving full-thickness skin grafts in an older observational cohort
Outcome
Partial graft loss after grafting delayed 12 to 14 days compared with immediate grafting
Time horizon
Postoperative graft-healing follow-up

What it means: The association supports deliberate delay as one tool for a selected recipient bed rather than an efficiency failure.

Limitations: The study was not a modern randomized trial. Indication and technique confounding prevent a universal recommendation to delay every nasal graft.

References: 14, 15

Evidence by the NumbersPeriocular repair evidence is broad but not standardized

Periocular repair evidence is broad but not standardized

3,678 repairs / 53 studies / 3 standardized assessments

Population
Patients undergoing periorbital reconstruction after Mohs surgery or excision
Outcome
Range of repair methods and use of defined grading, objective measurements, or independent cosmetic review
Time horizon
Across studies included in a 2023 systematic review

What it means: Many techniques are workable around the eye, but appearance comparisons are too inconsistently measured to support one universal repair hierarchy.

Limitations: Most studies were retrospective, defects and techniques varied, and only a small minority used standardized or independent outcome assessment.

References: 6

Evidence by the NumbersSelected staged outpatient flaps were well tolerated

Selected staged outpatient flaps were well tolerated

39 patients / mean satisfaction 95 ± 1.7 of 100

Population
Selected patients undergoing staged interpolation flaps under local anesthesia in one outpatient Mohs center
Outcome
Pain, anxiety, and patient satisfaction
Time horizon
During the staged reconstruction experience

What it means: A staged flap can be tolerable for selected patients even when the wound is large or deep.

Limitations: This was a small single-center cohort without a comparison group and does not establish that every patient or flap belongs in an office setting.

References: 31

Evidence by the NumbersFeasibility does not make a large repair routine

Feasibility does not make a large repair routine

436 repairs / 16.1% complications

Population
Large post-Mohs flaps, grafts, and complex closures performed under local anesthesia at one academic center
Outcome
Overall postoperative complications and adverse effects attributed to local anesthesia
Time horizon
Study follow-up after reconstruction

What it means: Selected large repairs were feasible under local anesthesia, but their meaningful complication burden must travel with that feasibility claim.

Limitations: The study was retrospective, single-center, and included mixed repair types selected for local anesthesia; the group rate does not predict one patient's risk.

References: 32

Evidence by the NumbersA prospective registry separates overall Mohs safety from repair-specific risk

A prospective registry separates overall Mohs safety from repair-specific risk

5,017 patients / 22 centers / 14,421 patient-years

Population
Patients undergoing Mohs micrographic surgery at 22 Spanish centers in the prospective REGESMOHS cohort
Outcome
Perioperative morbidity and midterm or scar-related complications, including hemorrhage, necrosis, dehiscence, infection, and aesthetic or functional scar alteration
Time horizon
Perioperative follow-up plus 14,421 accumulated patient-years

What it means: The cohort recorded 7.0% perioperative morbidity and 6.5% midterm or scar-related complications; individual complication rates were lower and varied by the outcome measured.

Limitations: The registry reflects selected real-world tumors and repairs. Associations with larger, deeper, unfinished, or more complex cases cannot isolate whether the defect, patient, or repair caused an outcome.

References: 35

Evidence by the NumbersOne antibiotic trial supports a narrow indication—not routine prophylaxis

One antibiotic trial supports a narrow indication—not routine prophylaxis

1 of 73 vs 8 of 69 infections

Population
Adults scheduled for a flap or graft on the nose or ear in Australian primary-care skin-cancer clinics; 154 randomized and 142 analyzed
Outcome
Surgical-site infection within 30 days after a single preoperative 2-g dose of cephalexin compared with placebo
Time horizon
30 days

What it means: The trial found fewer infections after cephalexin in this specifically defined higher-risk repair setting.

Limitations: The result does not establish routine antibiotic prophylaxis for every Mohs repair, other body sites, other procedures, allergic patients, or settings with different resistance patterns and stewardship policies.

References: 36

Expertise, Continuity, and Collaboration

Expertise, Continuity, and Collaboration

Mohs surgeons perform a large share of cutaneous reconstruction, particularly in cosmetically and functionally sensitive sites.5,33 Fellowship training integrates tumor extirpation, margin interpretation, and reconstruction and requires substantial supervised operative experience.34 The ACMS case-log requirement is an organizational training standard, not a peer-reviewed outcome comparison. This continuity can improve situational understanding: the surgeon knows the map, the sequence of stages, and how the defect evolved.

Training and practice volume are meaningful context, not outcome guarantees. No controlled evidence establishes that same-surgeon reconstruction is universally superior to a coordinated handoff, or that one specialty label produces the best result for every defect.

Collaboration is appropriate when it adds a needed capability. Examples include:

  • posterior-lamellar or lacrimal reconstruction;
  • major nasal lining, framework, or airway work;
  • extensive lip or commissure reconstruction;
  • tendon, nerve, or complex hand coverage;
  • bone involvement or free-tissue transfer;
  • general anesthesia or higher-acuity monitoring;
  • severe medical complexity; or
  • patient preference.

The referral should define ownership of margin clearance, temporary wound care, definitive reconstruction, postoperative concerns, and long-term surveillance. Fragmented care is avoidable when responsibilities and communication are explicit.

A Practical Decision Algorithm

A Practical Decision Algorithm

Step 1: Confirm the oncologic endpoint

  • Is the properly processed Mohs margin clear?
  • Is any non-Mohs pathology or staging information still pending?
  • Does tumor biology change whether tissue rearrangement should occur now?

Step 2: Describe the defect precisely

  • surface dimensions and shape;
  • missing tissue layers;
  • free margins and functional structures;
  • vascularity and prior treatment;
  • donor-site options; and
  • likely contraction and tension vectors.

Step 3: Identify the dominant reconstructive problem

  • coverage;
  • tension control;
  • contour or volume;
  • structural support;
  • lining;
  • function; or
  • a combination.

Step 4: Compare the least burdensome viable options

For each option, state:

  • the problem it solves;
  • the new problem it can create;
  • the number of stages;
  • the expected open-wound or donor-site burden;
  • the relevant uncertainty; and
  • what would trigger revision or collaboration.

Step 5: Match patient and setting

  • medical stability and medication plan;
  • anesthesia tolerance;
  • ability to manage aftercare;
  • access to staged follow-up;
  • monitoring and rescue resources; and
  • patient priorities.

Step 6: Document uncertainty without surrendering judgment

Record the recommended plan and the principal alternative. Explain what feature of the final defect makes one preferable. Avoid both false precision and a menu without guidance.

Clinical Questions Worth Asking Before Reconstruction

Clinical Questions Worth Asking Before Reconstruction

  1. Which tissue layers and functional structures are missing?
  2. What must not move as the wound heals?
  3. Which option solves the dominant problem with the least total burden?
  4. Is same-day repair serving the wound, or merely the schedule?
  5. What is the evidence type behind the recommendation?
  6. Which complication is most consequential for this site?
  7. Does the patient understand the stage count, donor site, and visible healing interval?
  8. Would another specialist or setting add a capability the case requires?
  9. Who owns urgent postoperative concerns and long-term surveillance?
  10. When should the outcome be judged, and what refinement options remain?
Frequently asked questions about reconstruction after Mohs surgery

Frequently Asked Questions

Is there a validated algorithm that chooses the repair from defect size?

No. Size is important, but depth, missing layers, free margins, tension, vascularity, host factors, and patient priorities prevent a reliable size-only algorithm.

Does a flap generally produce a better cosmetic result than a graft?

Not as a universal rule. Observational comparisons are confounded by defect selection and inconsistent outcome measurement. A flap and graft solve different problems.

Should all Mohs wounds be repaired the same day?

No. Same-day repair is common and appropriate for many defects. Second intention, planned delay, staging, referral, or medical optimization can be deliberate.

Does delaying reconstruction increase recurrence?

Reconstruction timing and cancer control are separate questions once appropriate oncologic clearance has been established. The available reconstruction literature does not support a blanket statement that a selected delay increases recurrence. Unresolved margins or tumor biology must be addressed before major tissue rearrangement.

Can a large or staged flap be performed under local anesthesia?

Yes in selected patients and experienced settings. Feasibility does not erase procedure-specific complications, patient burden, or the need for appropriate monitoring and rescue capability.

When is second intention most predictable?

Prediction is strongest when the surgeon integrates location, contour, depth, free-margin distance, vascularity, host healing, and the consequence of contraction. Concavity alone is insufficient.

Who should reconstruct the defect?

The surgeon or team with the skills, setting, and follow-up capability required by the final defect. Fellowship-trained Mohs surgeons routinely perform reconstruction; selected cases benefit from collaboration.

When should the scar be judged?

Function should be assessed early and repeatedly. Appearance often continues to change for many months, and patient-reported outcomes can improve through the first year.

Living-Review Update Triggers

Living-Review Update Triggers

This review should be reconsidered when new evidence materially changes:

  • comparative outcomes between reconstructive techniques for matched defects;
  • standardized patient-reported or blinded cosmetic outcomes;
  • timing of immediate versus delayed repair;
  • second-intention selection by body site;
  • anesthesia or setting safety for large repairs;
  • periocular, nasal lining/framework, lip, hand, or lower-extremity algorithms; or
  • training, referral, or multidisciplinary-care standards.
Who authored and reviewed this reconstruction after Mohs surgery guide?
Portrait of Dr. Thomas L.H. Hocker

About the Author

Dr. Thomas L.H. Hocker is a Harvard- and Mayo Clinic-trained, triple board-certified dermatologist, Mohs surgeon, and dermatopathologist. He is the Founding Director of Dermatologic Surgery at the UMKC School of Medicine and University Health and an Iron Surgeon lecturer at the American Society for Dermatologic Surgery. His work focuses on Mohs surgery for melanoma, complex and rare skin tumors, and aesthetic reconstruction after skin-cancer treatment. He co-authored the best-selling textbook Review of Dermatology and created Skin Trust to give patients and clinicians free access to clear, current, evidence-based education.

Read Dr. Hocker's background and mission

Dr. Hocker earned his bachelor's degree with honors from Yale University, where he was inducted into Phi Beta Kappa. As a Winston Churchill Scholar, he then studied at the University of Cambridge and earned an M.Phil. in Organic Chemistry. He received his M.D. with honors from Harvard Medical School, where his research focused on melanoma genetics. He completed dermatology residency at Mayo Clinic, a dermatopathology fellowship at the University of Michigan, and a Mohs micrographic and reconstructive surgery fellowship at Mayo Clinic. He is board-certified in Dermatology, Dermatopathology, and Mohs Micrographic Surgery.

Dr. Hocker serves as the Founding Director of Dermatologic Surgery at the UMKC School of Medicine and University Health. He is an internationally invited lecturer and speaker who teaches about Mohs surgery for melanoma, complex and rare tumors, dermatopathology, and aesthetic reconstruction after skin-cancer treatment. He has also been selected as an Iron Surgeon lecturer by the American Society for Dermatologic Surgery. He is the co-author of Review of Dermatology, a best-selling dermatology review textbook, and he continues to teach and mentor medical students, residents, and physicians.

Skin Trust exists because Dr. Hocker believes access to excellent medical knowledge should not depend on geography, wealth, or proximity to a major academic center. After training at several of the world's leading institutions, he sees that education as both a gift and a responsibility: to translate current evidence, expert judgment, and hard-won clinical experience into guidance that patients, families, and clinicians can actually use.

The mission is to increase awareness, reduce avoidable suffering, and give every person equal access to trustworthy, up-to-date information that can help them make the best decisions for their life. Skin Trust also extends Dr. Hocker's lifelong commitment to teaching, writing, and mentoring medical students and residents as they build lives and careers of purpose and service.

For Dr. Hocker, this work is also an expression of faith. He regards the opportunities to learn at Yale, Cambridge, Harvard, Mayo Clinic, and the University of Michigan as blessings from God. Teaching, writing, mentoring, and building Skin Trust are ways to pay those blessings forward in service to patients, learners, and the broader community. His faith is the personal motivation to do this work carefully, generously, and with integrity; it is not a condition of using or benefiting from this free resource.

References for this reconstruction after Mohs surgery review

References

  1. Chen A, Albertini JG, Bordeaux JS, et al. Evidence-based clinical practice guideline: reconstruction after skin cancer resection. J Am Acad Dermatol. 2021;85(2):423-441. doi:10.1016/j.jaad.2021.03.015.
  2. Alam M, Ibrahim O, Nodzenski M, et al. Adverse events associated with Mohs micrographic surgery: multicenter prospective cohort study of 20,821 cases at 23 centers. JAMA Dermatol. 2013;149(12):1378-1385. doi:10.1001/jamadermatol.2013.6255.
  3. Cook JL, Perone JB. A prospective evaluation of the incidence of complications associated with Mohs micrographic surgery. Arch Dermatol. 2003;139(2):143-152. doi:10.1001/archderm.139.2.143.
  4. Dowdle TS, Schmidt M, Winsett FT, Wagner RF. National trends in repair type selection after Mohs micrographic surgery: a benchmark analysis using TriNetX. Dermatol Surg. 2026;52(4):307-309. doi:10.1097/DSS.0000000000004851.
  5. Tan A, Castner NB, Slutsky JB. Mohs surgeons dominate cutaneous reconstructions in cosmetically and functionally sensitive sites: Medicare trends from 2013 to 2019. Dermatol Surg. 2023;49(6):539-543. doi:10.1097/DSS.0000000000003787.
  6. Archibald LK, et al. Periorbital reconstructive techniques following Mohs micrographic surgery or excisions: a systematic review. Arch Dermatol Res. 2023;315(7):1853-1861. doi:10.1007/s00403-022-02523-z.
  7. Veldhuizen IJ, Dusza SW, Kuo A, et al. Patient-reported quality of life and aesthetic satisfaction continues to improve for 1 year after Mohs surgery. J Am Acad Dermatol. 2025;93(2):444-450. doi:10.1016/j.jaad.2025.03.022.
  8. Müller FM, Dawe RS, Moseley H, Fleming CJ. Randomized comparison of Mohs micrographic surgery and surgical excision for small nodular basal cell carcinoma: tissue-sparing outcome. Dermatol Surg. 2009;35(9):1349-1354. doi:10.1111/j.1524-4725.2009.01240.x.
  9. Smeets NWJ, Krekels GAM, Ostertag JU, et al. Surgical excision vs Mohs' micrographic surgery for basal-cell carcinoma of the face: randomised controlled trial. Lancet. 2004;364(9447):1766-1772. doi:10.1016/S0140-6736(04)17399-6.
  10. van Kester MS, Goeman JJ, Genders RE. Tissue-sparing properties of Mohs micrographic surgery for infiltrative basal cell carcinoma. J Am Acad Dermatol. 2019;80(6):1700-1703. doi:10.1016/j.jaad.2019.01.057.
  11. National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Basal Cell Skin Cancer. Updated March 11, 2026.
  12. National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Squamous Cell Skin Cancer. Updated March 17, 2026.
  13. Sanniec K, Malafa M, Thornton JF. Simplifying the forehead flap for nasal reconstruction: a review of 420 consecutive cases. Plast Reconstr Surg. 2017;140(2):371-380. PMID: 28376026.
  14. Robinson JK, Dillig G. The advantages of delayed nasal full-thickness skin grafting after Mohs micrographic surgery. Dermatol Surg. 2002;28(9):845-851. doi:10.1046/j.1524-4725.2002.02031.x.
  15. Shah KS, Shah KS, Sharma AN, Song DH. Delayed full-thickness skin grafting after skin cancer resection: a systematic review. Dermatol Surg. 2026;52(5):433-439. doi:10.1097/DSS.0000000000004945.
  16. Jacobs MA, Christenson LJ, Weaver AL, et al. Clinical outcome of cutaneous flaps versus full-thickness skin grafts after Mohs surgery on the nose. Dermatol Surg. 2010;36(1):23-30. doi:10.1111/j.1524-4725.2009.01360.x.
  17. Mott KJ, Clark DP, Stelljes LS. Regional variation in wound contraction of Mohs surgery defects allowed to heal by second intention. Dermatol Surg. 2003;29(7):712-722.
  18. Kim DNW, Kibbi N, Christensen SR, Leffell DJ, Suozzi KC. Factors affecting outcomes of second-intent healing of nasal defects after Mohs micrographic surgery. Arch Dermatol Res. 2023;315(1):67-73. doi:10.1007/s00403-021-02306-y.
  19. van der Eerden PA, Lohuis PJFM, Hart AAM, Mulder WC, Vuyk H. Secondary intention healing after excision of nonmelanoma skin cancer of the head and neck. Plast Reconstr Surg. 2008;122(6):1747-1755. doi:10.1097/PRS.0b013e31818a9aaa.
  20. Kibbi N, Khan Y, Leffell DJ, Christensen SR, Suozzi KC. Predicting outcomes following second intent healing of periocular surgical defects. Arch Dermatol Res. 2021;313(6):483-489. doi:10.1007/s00403-020-02122-w.
  21. Kimura A, Ishii T, Hatta N. Efficacy and cosmetics of secondary intention healing for facial skin cancer: a single-center retrospective study. J Dermatol. 2026;53(7):1006-1012. doi:10.1111/1346-8138.70298.
  22. Schimmel J, Belcher M, Vieira C, Lawrence N, Decker A. Incidence of surgical site infections in second intention healing after dermatologic surgery. Dermatol Surg. 2020;46(12):1492-1497. doi:10.1097/DSS.0000000000002409.
  23. Pynn EV, Ransom M, Walker B, et al. Healing of excisional wounds on lower legs by secondary intention (HEALS) cohort study, part 1. Clin Exp Dermatol. 2022;47(10):1829-1838. doi:10.1111/ced.15273.
  24. Halani SH, Ma C, Pierce J, Sanniec K, Thornton JF. Nasal reconstruction after Mohs cancer resection: lessons learned from 2553 consecutive cases. Plast Reconstr Surg. 2021;148(1):171-182. doi:10.1097/PRS.0000000000008098.
  25. Patel SY, Itani K. Review of eyelid reconstruction techniques after Mohs surgery. Semin Plast Surg. 2018;32(2):95-102. doi:10.1055/s-0038-1642058.
  26. Ahmad J, Mathes DW, Itani KM. Reconstruction of the eyelids after Mohs surgery. Semin Plast Surg. 2008;22(4):306-318. doi:10.1055/s-0028-1095889.
  27. Sanniec K, Harirah M, Thornton JF. Lip reconstruction after Mohs cancer excision: lessons learned from 615 consecutive cases. Plast Reconstr Surg. 2020;145(2):533-542. doi:10.1097/PRS.0000000000006509.
  28. Bittner GC, Kubo EM, Fantini BC, Cerci FB. Auricular reconstruction after Mohs micrographic surgery: analysis of 101 cases. An Bras Dermatol. 2021;96(4):408-415. doi:10.1016/j.abd.2020.12.008.
  29. Johnson AR, Egeler SA, Wu WW, et al. Facial reconstruction after Mohs surgery: a critical review of defects involving the cheek, forehead, and perioral region. J Craniofac Surg. 2019;30(2):400-407. doi:10.1097/SCS.0000000000005074.
  30. Egeler SA, Johnson AR, Ibrahim AMS, et al. Reconstruction of Mohs defects located in the head and neck. J Craniofac Surg. 2019;30(2):412-417. doi:10.1097/SCS.0000000000005137.
  31. Wong N, Godinez-Puig V, Makdisi J, Zloty D, Kossintseva I. Interpolation flaps in the outpatient Mohs surgery setting: a prospective cohort study of patient pain, anxiety, and satisfaction. Dermatol Surg. 2021;47(1):24-29. doi:10.1097/DSS.0000000000002540.
  32. Nowsheen S, Pham VX, Eichstadt S, Jiang SIB. Clinical outcomes and complications in complex closures under local anaesthesia post-Mohs surgery. J Cutan Med Surg. 2025;29(4):351-354. doi:10.1177/12034754251316297.
  33. Donaldson MR, Coldiron BM. Dermatologists perform the majority of cutaneous reconstructions in the Medicare population: numbers and trends from 2004 to 2009. J Am Acad Dermatol. 2013;68(5):803-808. doi:10.1016/j.jaad.2013.01.026.
  34. American College of Mohs Surgery. Membership and dues: associate membership case-log requirements. Accessed July 24, 2026. https://www.mohscollege.org/members/membership-and-dues.
  35. Ruiz-Salas V, Sanmartin-Jiménez O, Garcés JR, et al; REGESMOHS. Complications associated with Mohs micrographic surgery: data from the nationwide prospective cohort REGESMOHS. Dermatology. 2022;238(2):320-328. doi:10.1159/000517010. PMID: 34380138.
  36. Rosengren H, Heal CF, Buttner PG. Effect of a single prophylactic preoperative oral antibiotic dose on surgical site infection following complex dermatological procedures on the nose and ear: a prospective, randomised, controlled, double-blinded trial. BMJ Open. 2018;8(4):e020213. doi:10.1136/bmjopen-2017-020213. PMID: 29674370.
  37. Miller EA, Friedrich J. Soft tissue coverage of the hand and upper extremity: the reconstructive elevator. J Hand Surg Am. 2016;41(7):782-792. doi:10.1016/j.jhsa.2016.04.020. PMID: 27288305.
  38. Massey PR, Rothstein BE, Gupta S, Sigel K, Schmults CD, Waldman A. Practice variation in utilization of flap or graft reconstruction among Veterans Affairs surgeons after extirpation of keratinocyte carcinoma on the nose. Dermatol Surg. 2021;47(9):1220-1223. doi:10.1097/DSS.0000000000003124. PMID: 34238788.